View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study-AMLSG 31-19/HOVON 501 - Daunorubicin 60 / Cytarabine 200 / Venetoclax (100/200/400), Acute Myeloid Leukemia and Myelodysplastic Syndrome, Induction I
Protocol-ID: 3140 V1.0 (Mini), STUDY-AMLSG 31-19/HOVON 501-DAUN60/CYTA200/VNTC(100/200/400), AML/MDS, Ind IStudy protocol, available to authorized participants only.
Indication(s)
- Acute Myeloid Leukemia; ICD-10 C92.0-, C92.5-, C93.0-, C92.8-, C92.6-, C92.7-, C92.9-
- Myelodysplastic Neoplasms; ICD-10 D46.-
MDS with elevated blasts -2
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 22.03.2026